Terapio uses human protein to counter-measure radiation

Terapio Corporation, located in Austin, Texas, is working to develop a radiation counter-measure for military, first responders and civilians from a naturally-occurring protein in the human body.

Terapio Corp. President and CEO Curt Bilby said the RLIP76 protein deals with oxidative stress, and can clean the body of toxins that cause significant damage to cells.

"We found a way where we can deliver additional protein, basically to deal with an oxidative stress situation," Bilby said, according to KHOU Houston. "That occurs with something like radiation poisoning or other types of insults to the body."

The process involves growing bacteria that produces the protein for Terapio.

"Then we purify away everything we don't want, and we're essentially left with a pure batch of this active protein that's identical to what you would find in your body," Terapio Corp. Vice President of Drug Development Henry Hebel said, KHOU Houston reports.

Bilby said the protein could be used by military and first responders who enter an area with radioactivity. The treatment would also be administered to civilians.

Approval for the product is approximately two to four years away.

Terapio Corp. was recognized at the National Institutes of Health, National Institute of Allergy and Infectious Diseases Advisory Council on Jan. 27 for its radiation countermeasure program. The company was awarded Phase 1 and Phase 2 SBIR grants, as well as participation in The DAIT Radiation/Nuclear Countermeasures Product Development program, the NIH Commercialization Assistance program and the Bridging Interventional Development Gaps program.

Organizations in this Story

National Institutes of Health

Want to get notified whenever we write about National Institutes of Health ?
Next time we write about National Institutes of Health, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.